top of page
  • Facebook
  • Twitter
  • Instagram
Bostwick Headshot.jpg

J. Michael Bostwick, MD, MFA
Professor of Psychiatry
Mayo Clinic College of Medicine

Treatment of Prolonged Grief Disorder
Thursday,  February 11, 2027
10:15 AM - 11:15 AM​

​

Medical Aid in Dying

Thursday, February 11, 2027
11:15 AM - 12:15 PM

J. Michael Bostwick, MD, MFA, is Professor of Psychiatry in the Mayo Clinic College of Medicine. He has written more than 125 scientific publications on diverse topics including suicide epidemiology and prevention, medical marijuana, and numerous psychosomatic topics. He serves on the editorial boards of two medical journals. He is an avid teacher at all levels of Mayo's medical school and psychiatry residency and frequently collaborates with trainees on research and writing projects. 

​

From 2013 to 2024, he served as Senior Associate Dean for Admissions for Mayo Clinic Alix School of Medicine. He holds Bachelor of Arts degrees from Yale University (1978) and the University of Hawaii (1982) in Art History and Zoology, respectively. In the interim between college and medical school, he was a newspaper reporter for the Cape Cod Times. He was graduated from Brown University's medical school (1987), and completed two years of pediatrics, an adult psychiatry residency, and consultation/liaison psychiatry fellowship at Harvard University-affiliated hospitals (1987-1993). He served as a Major in the United States Air Force at its premier teaching center at Lackland AFB, TX, from 1993 to 1998. Since leaving the Air Force, he has made his career at the Mayo Clinic, Rochester, Minnesota. In 2022, he was awarded a Master of Fine Arts degree in non-fiction writing from Bennington College and is working on a memoir exploring how the suicides of family, friends, and patients have shaped the psychiatrist he has become.
 

Lecture One Summary:

This presentation will examine the distinction between normal grief and prolonged or abnormal grief, with attention to the clinical features that may signal a need for additional evaluation or treatment. The session will review when medications may be appropriate, including for co-occurring psychiatric conditions, and will explore a range of therapeutic and supportive resources for grieving patients. Drawing on biological, psychological, and social perspectives, the presentation will provide a practical framework for understanding and managing grief across different clinical situations.

 

Lecture Two Summary:

This presentation will examine medical aid in dying (MAID) and the ways in which it differs from suicide as traditionally understood, with particular attention to its collaborative nature and its use in the context of serious or terminal illness. The session will explore how MAID is authorized and regulated across jurisdictions where it is permitted, highlighting important differences in eligibility and practice. The presentation will also consider the ethical implications of distinguishing MAID from suicide and how that distinction may shape clinical understanding, communication, and decision-making.

​Lecture One Goals and Learning Objectives:

  • Identify the target psychiatric illnesses with the best evidence base for improvement from psychedelic therapy.

  • Recognize the patients at highest risk for adverse events from the use of psychedelics.

  • Describe the model treatment environment for psychedelic therapy.

​

​Lecture Two Goals and Learning Objectives:

  • Incorporate a model that distinguishes MAID from suicide based on the collaborative nature of the former.

  • Explore the variability of what is permitted and how it is authorized in various jurisdictions that permit MAID.

  • Consider the ethical implications of understanding MAID as something other than suicide as traditionally understood.
    ​

​

Disclosures:

This presenter has no disclosures to provide.

bottom of page